Somatotopic Activation of Opioid Systems by Target-Directed Expectations of Analgesia

We induced specific expectations of analgesia on four different parts of the body to understand how endogenous opioid systems are activated by expectancies. The left hand, right hand, left foot, and right foot were simultaneously stimulated by means of a subcutaneous injection of capsaicin, which produces a painful burning sensation. Specific expectations of analgesia were induced by applying a placebo cream on one of these body parts and by telling the subjects that it was a powerful local anesthetic. In such a way, expectancy of the anesthetic effect was directed only toward the part on which the placebo cream was applied. We found that a placebo analgesic response occurred only on the treated part, whereas no variation in pain sensitivity was found on the untreated parts. If the same experiment was performed after an intravenous infusion of the opioid antagonist naloxone, this highly spatial-specific placebo response was totally abolished, indicating that it was completely mediated by endogenous opioid systems. These findings show that a spatially directed expectation of pain reduction is capable of inducing a specific effect only on the part of the body which is the target of the expectation. Most important, this specific effect is mediated by endogenous opioids, indicating that placebo-activated opioids do not act on the entire body but only on the part where expectancy is directed. This suggests that a highly organized and somatotopic network of endogenous opioids links expectation, attention, and body schema.

[1]  F. Benedetti,et al.  Inducing placebo respiratory depressant responses in humans via opioid receptors , 1999, The European journal of neuroscience.

[2]  F. Benedetti The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia , 1996, Pain.

[3]  F. Benedetti,et al.  Potentiation of placebo analgesia by proglumide , 1995, The Lancet.

[4]  E. Laska,et al.  ANTICIPATION OF ANALGESIA, A PLACEBO EFFECT , 1973, Headache.

[5]  A I Basbaum,et al.  Endogenous pain control mechanisms: review and hypothesis , 1979 .

[6]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.

[7]  R. LaMotte,et al.  Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. , 1991, Journal of neurophysiology.

[8]  I. Kirsch,et al.  Classical conditioning and the placebo effect , 1997, PAIN.

[9]  R. Melzack,et al.  Stimulation-produced analgesia: Evidence for somatotopic organization in the midbrain , 1982, Brain Research.

[10]  I. Kirsch,et al.  Mechanisms of Placebo Pain Reduction: An Empirical Investigation , 1996 .

[11]  F. Benedetti,et al.  The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression , 1998, Pain.

[12]  I. Wickram Classical conditioning and the placebo effect , 1989, Behavioral and Brain Sciences.

[13]  H. Fields,et al.  THE MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.

[14]  Ian Wickramasekera PhD A conditioned response model of the placebo effect , 1980, Biofeedback and self-regulation.

[15]  Batterman Rc,et al.  Placebo responsiveness--influence of previous therapy. , 1968 .

[16]  Donald D. Price,et al.  Central nervous system mechanisms of analgesia , 1976, Pain.

[17]  F. Benedetti,et al.  Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems , 1999, The Journal of Neuroscience.

[18]  C. Winter,et al.  Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs. , 1950, The Journal of pharmacology and experimental therapeutics.

[19]  L. Watkins,et al.  Organization of endogenous opiate and nonopiate pain control systems. , 1982, Science.

[20]  J. Levine,et al.  Influence of the method of drug administration on analgesic response , 1984, Nature.

[21]  F. Benedetti,et al.  THE NEUROBIOLOGY OF PLACEBO ANALGESIA: FROM ENDOGENOUS OPIOIDS TO CHOLECYSTOKININ , 1997, Progress in Neurobiology.

[22]  R. Rescorla Pavlovian conditioning. It's not what you think it is. , 1988 .

[23]  H. Fields Is there a facilitating component to central pain modulation , 1992 .

[24]  R. Dubner,et al.  Placebo and naloxone can alter post-surgical pain by separate mechanisms , 1983, Nature.

[25]  A. Goldstein,et al.  Partial antagonism of placebo analgesia by naloxone , 1983, Pain.

[26]  Nicholas J. Voudouris,et al.  The role of conditioning and verbal expectancy in the placebo response , 1990, Pain.

[27]  H. Fields,et al.  Placebo analgesia —a role for endorphins? , 1984, Trends in Neurosciences.

[28]  N. Voudouris,et al.  Conditioned response models of placebo phenomena: further support , 1989, Pain.

[29]  W. Brown,et al.  The Placebo Effect: An Interdisciplinary Exploration , 1997 .

[30]  P. Wilson Psychological and Neural Mechanisms of Pain , 1988 .

[31]  Irving Kirsch,et al.  Specifying nonspecifics: Psychological mechanisms of placebo effects. , 1997 .

[32]  M. T. Shipley,et al.  Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? , 1994, Trends in Neurosciences.